Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter?

Archives of Disease in Childhood

Volumn 92, Issue 12, 2007, Pages 1058-1061

  Crawley, Esther ^a,b   Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Centre for Child and Adolescent Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC FATIGUE SYNDROME; DEPRESSION; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC ASSOCIATION; HERITABILITY; HUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TWINS;

CHILD; DEPRESSION; DISEASES IN TWINS; EVIDENCE-BASED MEDICINE; FATIGUE SYNDROME, CHRONIC; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; TWIN STUDIES AS TOPIC;

EID: 36849016851     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.110502     Document Type: Review

References (40)

1. Chalder T, Goodman R, Wessely S, et al. Epidemiology of chronic fatigue syndrome and self reported myalgic encephalomyelitis in 5-15 year olds: cross sectional study. BMJ 2003;327(7416):654-5.
2. Jordan KM, Ayers PM, Jahn SC, et al. Prevalence of fatigue and chronic fatigue syndrome-like illness in children and adolescents. J Chronic Fatigue Syndr 2000;6(1):3-21.
3. Jones JF, Nisenbaum R, Solomon L, et al. Chronic fatigue syndrome and other fatiguing illnesses in adolescents: a population-based study. J Adolesc Health 2004;35(1):34-40.
4. Viner R, Hotopf M. Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study. BMJ 2004;329(7472):941.
5. Farmer A, Fowler T, Scourfield J, et al. Prevalence of chronic disabling fatigue in children and adolescents. Br J Psychiatry 2004;184:477-81.
6. Royal College of Paediatrics and Child Health. Evidence based guideline for the management of CFS/ME (chronic fatigue syndrome/myalgic encephalopathy) in children and young people. London: RCPCH, 2004.
7. CFS/ME Working Group. A report of the CFS/ME Working Group. A report to the Chief Medical Officer of an independent working group. London: Department of Health, 2002.
8. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006;367(9507):346-55.
9. Bell KM, Cookfair D, Bell DS, et al. Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. Rev infect Dis 1991;13(Suppl 1):S32-8.
10. Bell DS, Bell KM, Cheney PR. Primary juvenile fibromyalgia syndrome and chronic fatigue syndrome in adolescents. Clin Infect Dis 1994;18(Suppl 1):S21-3.
11. Hickie IB, Bansal AS, Kirk KM, et al. A twin study of the etiology of prolonged fatigue and immune activation. Twin Res 2001;4(2):94-102.
12. Hickie I, Kirk K, Martin N. Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol Med 1999;29(2):259-68.
13. Hickie I, Bennett B, Lloyd A, et al. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study. Psychol Med 1999;29(2):269-77.
14. Buchwald O, Herrell R, Ashton S, et al. A twin study of chronic fatigue. Psychosom Med 2001;63(6):936-43.
15. National Institute for Health and Clinical Excellence. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy); diagnosis and management. Clinical guidance 53. London: NICE, August 2007.
16. Farmer A, Scourfield J, Martin N, et al. Is disabling fatigue in childhood influenced by genes? Psychol Med 1999;29(2):279-82.
17. Fowler TA, Rice F, Thapar A, et al. Relationship between disabling fatigue and depression in children: genetic study. Br J Psychiatry 2006;189:247-53.
18. Turkheimer E. Spinach and ice cream: why social science is so difficult. In: DiLally LF, ed. Behavior genetic principles - perspectives in development, personality, and psychopathology. Washington, DC: American Psychological Association, 2004:161-89.
19. Davey Smith G, Ebrahim S. Epidemiology-is it time to call it a day? Int J Epidemiol 2001;30(1):1-11.
20. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Inf J Epidemiol 2003;32(1):1-22.
21. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330(7499):1076-9.
22. Torpy DJ, Bachmann AW, Grice JE, et al. Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J Clin Endocrinol Metab 2001;86(8):3692-700.
23. Torpy DJ, Bachmann AW, Gartside M, et al. Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr Res 2004;30(3):417-29.
24. Underhill JA, Mahalingam M, Peakman M, et al. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet 2001;28(3):425-8.
25. Smith J, Fritz EL, Kerr JR, et al. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol 2005;58(8):860-3.
26. Carlo-Stella N, Badulli C, De SA, et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006;24(2):179-82.
27. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361(9360): 865-72.
28. Schadt EE, Lamb J, Yang X, et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005;37(7):710-17.
29. Powell R, Ren J, Lewith G, et al. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy 2003;33(10):1450-6.
30. Kaushik N, Fear D, Richards SC, et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 2005;58(8):826-32.
31. Vernon SD, Unger ER, Dimulescu IM, et al. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 2002;18(4):193-99.
32. Vollmer-Conna U, Aslakson E, White PD. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 2006;7(3):355-64.
33. Aslakson E, Vollmer-Conna U, White PD. The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue. Pharmacogenomics 2006;7(3):365-73.
34. Smith AK, White PD, Aslakson E, et al. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006;7(3):387-94.
35. Goertzel BN, Pennachin C, de Souza CL, et al. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 2006;7(3):475- 83.
36. Fang H, Xie Q, Boneva R, et al. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 2006;7(3):429-40.
37. Whistler T, Taylor R, Craddock RC, et al. Gene expression correlates of unexplained fatigue. Pharmacogenomics 2006;7(3):395- 405.
38. Carmel L, Efroni S, White PD, et al. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006;7(3):375-86.
39. Broderick G, Craddock RC, Whistler T, et al. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 2006;7(3):407-19.
40. Sterne J, Kirkwood BR. In:, Goodgame F, ed. Essential medical statistics. Maiden, MA: Blackwell Science, 2003:98-106.